121
Participants
Start Date
February 1, 2021
Primary Completion Date
June 13, 2022
Study Completion Date
June 13, 2022
K-877 ER 0.2 mg/day morning administration (once daily)
K-877 ER 0.2 mg tablet
K-877 ER 0.2 mg/day evening administration (once daily)
K-877 ER 0.2 mg tablet
Saiseikai Futsukaichi Hospital, Fukuoka
National Hospital Organization Takasaki General Medical Center, Gunma
Hasegawa Medicine Clinic, Hokkaido
Japan Community Health care Organization Hokkaido Hospital, Hokkaido
Minami Akatsuka Clinic, Ibaraki
Saiseikai Yokohamashi Nanbu Hospital, Kanagawa
Kinugawa Cardiology Clinic, Osaka
Kyosokai AMC NISHI-UMEDA Clinic, Osaka
Medical corporation Tani clinic, Osaka
Shiraiwa medical clinic, Osaka
Cosmos medical corporation Aozora total clinic, Saitama
Akasaka Chuou Clinic, Tokyo
Medical Corporation Chiseikai Tokyo Center Clinic, Tokyo
Shimokitazawa Tomo Clinic, Tokyo
Kowa Company, Ltd.
INDUSTRY